Harry T Whelan, MD: Clinical Trials

3 trials sponsored by Harry T Whelan, MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Terminated 1

Follow Harry T Whelan, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Photofrin photodynamic therapy. - Brain Tumor, Recurrent
Phase 2TerminatedHarry T Whelan, MD12015-06-012019-08-20
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Photofrin (porfimer sodium) & photodynamic therapy. - Brain Tumor, Recurrent
Phase 1CompletedHarry T Whelan, MD52013-03-012019-02-25
Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)
Part 1 Levulan injection, Part 1 Levulan surface application, Part 1 Levulan surface application twice - Neurofibromatoses
Phase 1CompletedHarry T Whelan, MD202012-03-122021-06-18

Conditions studied

Astrocytoma (2)  ·  Brain Neoplasms (2)  ·  Chordoma (2)  ·  Craniopharyngioma (2)  ·  Germinoma (2)  ·  Glioblastoma (2)  ·  Glioma (2)  ·  Meningioma (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Oligodendroglioma (2)  ·  Optic Nerve Glioma (2)  ·  Pituitary Neoplasms (2)  ·  Ependymoma (1)  ·  Glioma, Subependymal (1)  ·  Medulloblastoma (1)

Interventions

Aminolevulinic Acid (1)  ·  Dihematoporphyrin Ether (1)  ·  Percutaneous Collagen Induction (1)  ·  Photochemotherapy (1)

Countries

United States (3)

Top investigators

Jeff Knipstein, MD (1)

Results publications

PMID 33470897